Gallagher Security Corp. and MyCelium Warehouse Inc. Announce David Garcia as CMO and Andrew Boyd-Jones as CFO and Vice Chairman
Kelowna, British Columbia--(Newsfile Corp. - June 9, 2021) - Gallagher Security Corp. (CSE: GLL) ("GLL" or the "Company") and MyCelium Warehouse Inc. ("MyCelium") are pleased to appoint David Garcia as Chief Marketing Officer and Andrew Boyd-Jones as CFO and Vice-Chairman.
David Garcia - David's immense experience in brand-building, consumer product, and business-to-business marketing, will be a significant asset to the MyCelium in the burgeoning mycological industry. In addition to creating his own label imprint, Solmatic Records in 2010, he has created and launched multi-million dollar nightclubs and international events.
Andrew Boyd-Jones founded and currently serves as CEO s Founder, CEO and Director of multiple companies and has been involved in entrepreneurship ac of The Tellson Companies, which includes Tellson Holdings, Tellson Securities (a FINRA and SEC licensed broker/dealer), Tellson Equities, Tellson Corporate Services and Tellson Ventures. Each of these companies either provides financial advisory services or placement services for or direct investment in emerging market, micro-cap or middle market companies. Prior to his activities with Tellson, Mr. Boyd-Jones was affiliated with the UHNW Spencer Family Office (Holding Capital Group - HCG) and led initiatives in private equity, hedge funds and commodity investing. He also launched the HCG Mezzanine Development Fund as a Principal of the firm. Early in his career Mr. Boyd-Jones founded Trenwith Securities, a FINRA-licensed Broker-Dealer that was ultimately responsible for raising over a billion dollars of capital and which was ultimately sold to BDO. He started his finance career at Bankers Trust in LA, executing the early transactions of KKR and Green and Partners.
Mr. Boyd-Jones has participated in all facets of the deal business - as investment banker, lender, private equity professional, owner and partner.
Mycelium Inc. is focused on being in the forefront of new process and growing techniques so that more people can harness the incredible healing powers of the fungi world. We welcome everyone from first time grower to the experienced mycologist to the MyCelium Family.
ON BEHALF OF THE BOARD OF DIRECTORS
President and Director
For further information, please contact:
The CSE does not accept responsibility for the adequacy or accuracy of this news release.
This news release may contain forward-looking statements or information including but not limited to comments regarding the potential signing of the definitive agreement, the closing of the potential transaction with MyCelium, receipt of stock exchange approval for the proposed transaction, statements about MyCelium and its intentions and plans, and other matters. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements and the Company undertakes no obligation to update such statements, except as required by law.
There can be no assurance that the proposed transaction will be completed.
All information in this news release concerning MyCelium has been provided for inclusion herein by MyCelium. Although the Company has no knowledge that would indicate that any information contained herein concerning MyCelium is untrue or incomplete, the Company assumes no responsibility for the accuracy or completeness of any such information. Investors are cautioned that, except as disclosed in a listing statement to be prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of the Company should be considered highly speculative.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/87111
News Provided by Newsfile Corp.